| The structural basis of T-cell receptor (TCR) activation: An enduring enigma RA Mariuzza, P Agnihotri, J Orban Journal of Biological Chemistry 295 (4), 914-925, 2020 | 146 | 2020 |
| Synthesis, structure–activity relationships, and biological studies of chromenochalcones as potential antileishmanial agents R Shivahare, V Korthikunta, H Chandasana, MK Suthar, P Agnihotri, ... Journal of Medicinal Chemistry 57 (8), 3342-3357, 2014 | 44 | 2014 |
| Supramolecular Assembly of Toll-like Receptor 7/8 Agonist into Multimeric Water-Soluble Constructs Enables Superior Immune Stimulation In Vitro and In Vivo AK Andrianov, A Marin, R Wang, H Karauzum, A Chowdhury, P Agnihotri, ... ACS applied bio materials 3 (5), 3187-3195, 2020 | 29 | 2020 |
| Discovery of novel inhibitors for Leishmania nucleoside diphosphatase kinase (NDK) based on its structural and functional characterization AK Mishra, N Singh, P Agnihotri, S Mishra, SP Singh, BK Kolli, KP Chang, ... Journal of computer-aided molecular design 31, 547-562, 2017 | 27 | 2017 |
| Identification of Novel Inhibitors of Leishmania donovani γ-Glutamylcysteine Synthetase Using Structure-Based Virtual Screening, Docking, Molecular Dynamics … P Agnihotri, AK Mishra, S Mishra, VK Sirohi, AA Sahasrabuddhe, ... Journal of chemical information and modeling 57 (4), 815-825, 2017 | 25 | 2017 |
| Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization BG Pierce, ZY Keck, R Wang, P Lau, K Garagusi, K Elkholy, EA Toth, ... Journal of virology 94 (22), 10.1128/jvi. 00704-20, 2020 | 23 | 2020 |
| In Vivo and In Vitro Potency of Polyphosphazene Immunoadjuvants with Hepatitis C Virus Antigen and the Role of Their Supramolecular Assembly AK Andrianov, A Marin, R Wang, A Chowdhury, P Agnihotri, AS Yunus, ... Molecular pharmaceutics 18 (2), 726-734, 2020 | 18 | 2020 |
| Novel protein–protein interaction between spermidine synthase and S-adenosylmethionine decarboxylase from Leishmania donovani AK Mishra, P Agnihotri, VK Srivastava, JV Pratap Biochemical and Biophysical Research Communications 456 (2), 637-642, 2015 | 17 | 2015 |
| Cooperative binding of T cell receptor and CD4 to peptide-MHC enhances antigen sensitivity MN Rushdi, V Pan, K Li, HK Choi, S Travaglino, J Hong, F Griffitts, ... Nature communications 13 (1), 7055, 2022 | 16 | 2022 |
| Peptide–MHC binding reveals conserved allosteric sites in MHC class I-and class II-restricted T cell receptors (TCRs) Y He, P Agnihotri, S Rangarajan, Y Chen, MC Kerzic, B Ma, R Nussinov, ... Journal of molecular biology 432 (24), 166697, 2020 | 15 | 2020 |
| Characterization of a novel putative S-adenosylmethionine decarboxylase-like protein from Leishmania donovani SP Singh, P Agnihotri, JV Pratap Plos one 8 (6), e65912, 2013 | 8 | 2013 |
| Biochemical and biophysical characterization of Leishmania donovani gamma-glutamylcysteine synthetase P Agnihotri, SP Singh, AK Shakya, JV Pratap Biochemistry and Biophysics Reports 8, 127-138, 2016 | 7 | 2016 |
| Epitope mapping of therapeutic antibodies targeting human LAG3 P Agnihotri, AK Mishra, P Agarwal, KM Vignali, CJ Workman, DAA Vignali, ... The Journal of Immunology 209 (8), 1586-1594, 2022 | 5 | 2022 |
| Cooperative binding of TCR and CD4 to pMHC enhances TCR sensitivity MN Rushdi, V Pan, K Li, HK Choi, S Travaglino, J Hong, F Griffitts, ... bioRxiv, 2021.11. 22.469547, 2021 | 3 | 2021 |
| Advanced BioScience Laboratories P Agnihotri Inc.(ABL), United States, 0 | 2 | |
| CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 determined using a bivalent Fab as fiducial marker AK Mishra, S Shahid, SS Karade, P Agnihotri, A Kolesnikov, SS Hasan, ... Structure 31 (10), 1149-1157. e3, 2023 | 1 | 2023 |
| Crystal structure and characterization of nucleoside diphosphate kinase from Vibrio cholerae P Agnihotri, AK Shakya, AK Mishra, JV Pratap Biochimie 190, 57-69, 2021 | 1 | 2021 |
| Scale up of a lentiviral production process from the iCELLis® nano bioreactor to the iCELLis 500+ bioreactor I Pelletier, V Pasupuleti, P Agnihotri, Y Do, Z Sandalon, K Bayne, ... Cytotherapy 23 (5), S154, 2021 | | 2021 |
| Scale up of a Lentiviral Production Process from the iCELLis (R) Nano Bioreactor to the iCELLis 500+ Bioreactor I Pelletier, V Pasupuleti, P Agnihotri, Y Do, Z Sandalon, K Bayne, ... MOLECULAR THERAPY 29 (4), 407-407, 2021 | | 2021 |
Roy MariuzzaVerified email at ibbr.umd.edu
